C. Hawkey

发表

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Raghavendra C Kamath, A. T. Adebanjo, Jennifer L. Small, 2020, Lancet.

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment

R. Terkeltaub, C. Coupland, M. Doherty, 2022, Rheumatology advances in practice.

High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Hailiang Huang, Stephan Ripke, Andre Franke, 2014, Nature Genetics.

A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain

M. Doherty, S. Aspley, Nicola Hill, 2011, Annals of the rheumatic diseases.

Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis.

E. Nasonov, P. Svoboda, E. Pikhlak, 2004, The Journal of rheumatology.

Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)

R. Prescott, C. Lees, J. Satsangi, 2023, Cellular and molecular gastroenterology and hepatology.

An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.

S. Targan, M. Kamm, C. Hawkey, 2001, Gastroenterology.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Judy H. Cho, C. Gieger, H. Hakonarson, 2015 .

NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease

Jimmy D Bell, J. Danesh, G. McVean, 2017, Mucosal Immunology.

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

David C. Wilson, Judy H. Cho, C. Gieger, 2012, Nature.

Exploring the genetic architecture of inflammatory bowel disease 1 by whole genome sequencing identifies association at ADCY7 2

M. Tremelling, N. Prescott, L. Jostins, 2016 .

Exploring the genetic architecture of inflammatory bowel disease

Loukas Moutsianas, Alison Simmons, Joshua Randall, 2016 .

Exploring the genetic architecture of inflammatory bowel disease 1 by whole genome sequencing identifies association at ADCY7 2

M. Tremelling, N. Prescott, L. Jostins, 2016 .